OptiScan Biomedical Investors


Hercules Technology Growth Capital

At Hercules, we provide venture debt to entrepreneurial companies at all stages of development to further their growth and help them achieve key milestones. In addition to the capital we provide, many times the access to our network of contacts and simple business advice can prove to be equally as valuable.  Visit their website.


JJDC (Johnson & Johnson)

Johnson & Johnson Development Corporation (JJDC) is the venture capital subsidiary of Johnson & Johnson. JJDC is comprised of experts and leaders in the health care and technology venture communities who identify early market indicators, health care trends, and strategic investment opportunities. Unlike traditional venture capital firms, JJDC determines the success of an investment’s performance not only in financial returns, but also in the viability of providing strategic growth options for Johnson & Johnson.  Visit their website.


MedVenture Associates

MVA was founded in 1986 and identifies and invests in new medical technologies and the entrepreneurs developing them to create the next generation of medical practice.  Visit their website.


Mitsui Global Investment

Mitsui Global Investment (MGI) is a subsidiary of Mitsui & Co., Ltd., which invests in opportunities that have potential for growth. While we are headquartered in Tokyo, we also have offices in Silicon Valley, Beijing, Mumbai. Our investments reach beyond these geographical barriers, allowing us to build a diversified global portfolio.  Visit their website.


Morgenthaler Ventures

Morgenthaler Ventures is a premier venture capital firm, dedicated to helping entrepreneurs build valuable companies. Since 1968, we have invested in approximately 300 companies.The Morgenthaler Life Science Team consists of a highly experienced group of investors and operators who have invested and directed the exits of some of the largest venture-backed deals since 2000.  Visit their website.


NGN Capital

NGN Capital is a venture capital firm dedicated to healthcare investing, focusing on ventures with the potential to achieve above average private equity returns with an emphasis on later stage investments. The funds have flexibility to invest in a broad cross section of healthcare and biotechnology segments including drug products, medical devices and other healthcare segments like services. The funds are diversified by stage, from later stage to selected early stage opportunities, as well as by geography by investing predominantly in the US and in Europe.  Visit their website.


Wexford Capital LP

Wexford Capital LP is an SEC registered investment advisor with over $4 billion of assets under management. The firm, which was formed in 1994, manages a series of hedge funds and private equity funds from its Greenwich, CT headquarters.  Visit their website.